At the time of writing, Tango Therapeutics Inc [TNGX] stock is trading at $13.01, up 11.29%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TNGX shares have gain 10.72% over the last week, with a monthly amount glided 45.20%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Overweight rating on August 19, 2025, and set its price target to $11. On July 17, 2024, Jefferies initiated with a Buy rating and assigned a price target of $19 on the stock. Cantor Fitzgerald started tracking the stock assigning an Overweight rating. Piper Sandler initiated its recommendation with an Overweight and recommended $18 as its price target on February 12, 2024. B. Riley Securities started tracking with a Buy rating for this stock on December 08, 2023, and assigned it a price target of $16. In a note dated October 20, 2022, H.C. Wainwright upgraded a Buy rating on this stock but restated the target price of $10.
For the past year, the stock price of Tango Therapeutics Inc fluctuated between $1.03 and $12.62. Currently, Wall Street analysts expect the stock to reach $13.67 within the next 12 months. Tango Therapeutics Inc [NASDAQ: TNGX] shares were valued at $13.01 at the most recent close of the market. An investor can expect a potential return of 5.07% based on the average TNGX price forecast.
Analyzing the TNGX fundamentals
According to Tango Therapeutics Inc [NASDAQ:TNGX], the company’s sales were 66.50M for trailing twelve months, which represents an 363.61% jump. Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -1.66%, Pretax Profit Margin comes in at -1.51%, and Net Profit Margin reading is -1.51%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -0.61 and Total Capital is -0.58. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Tango Therapeutics Inc [NASDAQ:TNGX] has a current ratio of 8.88. As well, the Quick Ratio is 8.88, while the Cash Ratio is 3.16. Considering the valuation of this stock, the price to sales ratio is 26.35, the price to book ratio is 9.07.
Transactions by insiders
Recent insider trading involved Third Rock Ventures IV, L.P., 10% Owner, that happened on Oct 23 ’25 when 0.48 million shares were sold. 10% Owner, Third Rock Ventures IV, L.P. completed a deal on Oct 23 ’25 to buy 0.48 million shares. Meanwhile, 10% Owner Third Rock Ventures IV, L.P. sold 0.5 million shares on Sep 25 ’25.
